• Sign In
  • Sign Out
  • My Account
Subscribe
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
  • Special reports
Clarivate
  • Data Snapshots
  • BioWorld
  • BioWorld MedTech
  • Infographics: Dynamic digital data analysis
  • Index insights
  • Special reports
  • Infographics: Dynamic digital data analysis
  • Trump administration impacts
  • Biopharma M&A scorecard
  • BioWorld 2024 review
  • BioWorld MedTech 2024 review
  • BioWorld Science 2024 review
  • Women's health
  • China's GLP-1 landscape
  • PFA re-energizes afib market
  • China CAR T
  • Alzheimer's disease
  • Coronavirus
  • More reports can be found here

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 13, 2005

View Archived Issues

Roche reviews H1 developments

Read More

Rotigaptide: potential as a therapy for osteoporosis

Read More

OncoMed completes Series A financing

Read More

Novo Nordisk and Sangamo BioSciences enter agreement for ZFP technology

Read More

Novel PTP-1B inhibitor synthesized by Incyte

Read More

Good safety and pharmacokinetics of AEOL-10150 in ALS patients

Read More

COR-100140: Orally active MIF antagonist with preclinical efficacy in inflammatory diseases

Read More

Ostarine moves into phase II development for muscle wasting

Read More

MEK inhibitor AR-00241389 active in animal models of arthritis and IBS

Read More

Progenics updates findings on HIV entry inhibitor PRO-140

Read More

Progenics updates methylnaltrexone progress

Read More

MedImmune and VasGene to develop monoclonal antibodies for cancer

Read More

TAP and Ilyang sign licensing agreement for ilaprazole

Read More

Sanctura XR enters phase III program for overactive bladder

Read More

Applied NeuroSolutions submits pre-IDE for Alzheimer's disease test

Read More

Columbia completes lidocaine vaginal gel pharmacokinetics study

Read More

Bexxar receives Canadian approval

Read More

MorphoSys and Shionogi sign HuCAL technology license agreement

Read More

SCH-6: characterization of a potent anti-HCV agent

Read More

New 5-HT2C agonist shown to be a therapeutic candidate for obesity

Read More

SGL-0010: a novel orally active SGLT inhibitor for diabetes

Read More

NIH sponsors drug discovery group to discover mood disorder drugs

Read More

Dosing begins in Russian phase II study of Dimebon for Alzheimer's disease

Read More

Novel analgesic agents in early development

Read More

Adenosine A2A receptor antagonists for Parkinson's claimed in Kyowa Hakko patent

Read More

Novel agents for thrombotic disorders imparted by Daiichi

Read More

Studies confirm that prasugrel is effective in inhibiting platelet aggregation

Read More

Good antitumor response reported with lenalidomide/dexamethasone in multiple myeloma

Read More

Surinabant (SR-147778) shows promising results in various rodent models of ADHD

Read More

Partial agonist of alpha7nAChRs produces antidepressant effect in rodents

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 7, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for July 7, 2025.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for July 1, 2025
  • Illustration of the β2-adrenergic receptor

    Exercise-mimicking compound offers alternative to GLP-1 therapies

    BioWorld
    An experimental drug for treating diabetes and obesity has been shown to lower blood sugar levels and increase fat burning. It is a β2-adrenergic receptor (β2AR)...
  • Deal handshake with coin, chart background

    After axing 95% workforce, Vor bets $4B+ on Remegen’s telitacicept

    BioWorld
    Just a month after laying off 147 employees and announcing plans to mull “strategic alternatives,” Vor Biopharma Inc. reported raising $175 million in private...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe